Vigabatrin increases human brain homocarnosine and improves seizure control

Annals of Neurology

Volumn 44, Issue 6, 1998, Pages 948-952

  Petroff, Ognen A C ^a   Mattson, Richard H ^a   Behar, Kevin L ^a   Hyder, Fahmeed ^b   Rothman, Douglas L ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; CARBAMAZEPINE; GABAPENTIN; HOMOCARNOSINE; LAMOTRIGINE; PHENYTOIN; PRIMIDONE; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ADULT; ANTICONVULSANT THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; FEMALE; GABAERGIC SYSTEM; HUMAN; MALE; NEUROMODULATION; NEUROTRANSMISSION; OCCIPITAL LOBE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SEIZURE;

EID: 0031793772     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410440614     Document Type: Article

References (32)

1. Jackson MC, Scollard DM, Mack RJ, Lenney JF. Localization of a novel pathway for the liberation of GABA in human CNS. Brain Res Bull 1994;33:379-385
2. Jakobs C, Jaeken J, Gibson KM. Inherited disorders of GABA metabolism. J Inherit Metab Dis 1993;16:704-715
3. Gjessing LR, Lunde HA, Morkrid L, et al. Inborn errors of carnosine and homocarnosine metabolism. J Neural Transm 1990;29:91-106
4. Kish SJ, Perry TL, Hansen S. Regional distribution of homocarnosine, homocarnosine-carnosine synthetase, and homocarnosinase in human brain. J Neurochem 1979;32:1629-1636
5. Perry TL, Berry K, Hansen S, et al. Regional distribution of amino acids in human brain obtained at autopsy. J Neurochem 1971;18:513-519
6. Perry T. Cerebral amino acid pools. In: Lajtha A, ed. Handbook of neurochemistry, vol 1. 2nd ed. New York: Plenum Press, 1982:151-180
7. Perry TL, Hansen S, Gandham SS. Postmortem changes of amino compounds in human and rat brain. J Neurochem 1981; 36:406-412
8. Perry TL, Kish SJ, Sjaastad O, et al. Homocarnosinosis: increased content of homocarnosine and deficiency of homocarnosinase in brain. J Neurochem 1979;32:1637-1640
9. Jung MJ, Palfreyman MG. Vigabatrin: mechanisms of action. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic drugs. 4th ed. New York: Raven Press, 1995:903-913
10. Kocsis JD, Mattson RH. GABA levels in the brain: a target for new antiepileptic drugs. Neuroscientist 1996;6:326-334
11. Marson AG, Kadir ZA, Hutton JL, Chadwick DW. The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 1997;38:859-880
12. Petroff OAC, Rothman DL. Measuring human brain GABA in vivo: effects of GABAtransaminase inhibition with vigabatrin. Mol Neurobiol 1998;16:97-121
13. Grove J, Schechter PJ, Tell G, et al. Increased gamma-aminobutyric acid (GABA), homocarnosine, and beta-alanine in cerebrospinal fluid of patients treated with gamma-vinyl GABA (4-amino-hex-5-enoic acid). Life Sci 1981;28:2431-2439
14. Schechter PJ, Hanke NFJ, Grove J, et al. Biochemical and clinical effects of gamma-vinyl-GABA in patients with epilepsy. Neurology 1984;34:182-186
15. Ben-Menachem E, Perrson LI, Schechter PJ, et al. Effects of single doses of vigabatrin on CSF concentrations of GABA, homocarnosine, homovanillic acid and 5-hydroxyindoleacetic acid in patients with complex partial epilepsy. Epilepsy Res 1988;2: 96-101
16. Halonen T, Lehtinen M, Pitkänen A, et al. Inhibitory and excitatory amino acids in CSF of patients suffering with complex partial seizures during chronic treatment with gamma-vinyl GABA (vigabatrin). Epilepsy Res 1988;2:246-252
17. Ben-Menachem E, Persson LI, Schechter PJ, et al. The effect of different vigabatrin treatment regimens on CSF biochemistry and seizure control in epileptic patients. Br J Clin Pharmacol 1989;27(Suppl 1):79S-85S
18. Reikkinen PJ, Ylinen A, Halonen T, et al. Cerebrospinal fluid GABA and seizure control with vigabatrin. Br J Clin Pharmacol 1989;27(Suppl 1):87S-94S
19. Ben-Menachem E, Persson LI, Mumford JP, et al. The effect of long-term vigabatrin therapy on selected neurotransmitter concentrations in cerebrospinal fluid. J Child Neurol 1991;6(Suppl 2):2S11-2S16
20. Kälviäinen R, Halonen T, Pitkänen A, Reikkinen PJ. Amino acid levels in the cerebrospinal fluid of newly diagnosed epileptic patients: effect of vigabatrin and carbamazepine monotherapies. J Neurochem 1993;60:1244-1250
21. Grove J, Schechter PJ, Tell G, et al. Artifactual increases in the concentration of free GABA in samples of human cerebrospinal fluid are due to degradation of homocarnosine. J Neurochem 1982;39:1061-1065
22. Haegele KD, Schwartz JJ, Schoun J, et al. 2-Pyrrolidinone is human cerebrospinal fluid: a major constituent of total γ-aminobutyric acid. J Neurochem 1987;49:1402-1406
23. Schechter PJ, Sjoerdsma A. Clinical relevance of measuring GABA concentrarions in cerebrospinal fluid. Neurochem Res 1990;15:419-423
24. Pan JW, Hamm JR, Rothman DL, Shulman RG. Intracellular pH in human skeletal muscle by 1H NMR. Biochemistry 1988; 85:7836-7839
25. Rothman DL, Behar KL, Prichard JW, Petroff OAC. Homocarnosine and the measurement of neuronal pH in patients with epilepsy. Magn Reson Med 1997;32:924-929
26. Mattson RH, Cramer JA, Collins JF, Department of Veterans Affairs Epilepsy Cooperative Studies No. 118 and No. 264 Group. Prognosis for total control of complex partial and secondarily generalized tonic clonic seizures. Neurology 1996;47:68-76
27. Behar KL, Rothman DL, Spencer DD, Petroff OAC. Analysis of macromolecule resonances in 1H NMR spectra of human brain. Magn Reson Med 1994;32:294-302
28. Rothman DL, Petroff OAC, Behar KL, Mattson RH. Localized 1H NMR measurements of GABA levels in human brain in vivo. Proc Natl Acad Sci USA 1993;90:5662-5666
29. Petroff OAC, Rothman DL, Behar KL, Mattson RH. Initial observations on the effect of vigabatrin on the in vivo 1H spectroscopic measurements of GABA, glutamate, and glutamine in human brain. Epilepsia 1995;36:457-464
30. Petroff OAC, Pleban LA, Spencer DD. Symbiosis between in vivo and in vitro NMR spectroscopy: the creatine, N-acetylaspartate, glutamate, and GABA content of epileptic human brain. Magn Reson Imaging 1995;13:1197-1211
31. Gardner MJ, Altman DG. Statistics with confidence. London: BMJ Press, 1989
32. Petroff OAC, Rothman DL, Behar KL, Mattson RH. Human brain γ-aminobutyric acid (GABA) levels and seizure control following initiation of vigabatrin therapy. J Neurochem 1996; 67:2399-2404